Company news
EVE Health Group Limited news in 2016
EVE Health Group Limited's news releases, calls and decks from 2016, newest first.
$1.6m Placement for Omni Innovation Investment
December 23, 2016
Notification of Rights Issue Shortfall
December 9, 2016
Omni Innovation Market Update
December 1, 2016
Omni Innovation secures UK Distribution Deal
November 20, 2016
Placement to Chinese Pharmaceutical and Investment Group
November 9, 2016
New Study- GlucoControl Improves Long-Term Glycaemic Control
September 20, 2016
Omniblend Innovation Enters into US Representation Deal
August 23, 2016
GlucoControl Momentum
July 4, 2016
GlucoControl Pre-Meal Drink Launched
May 5, 2016
Extension of Omniblend Innovation Tranche 2 Settlement
March 31, 2016
Non-Renounceable Issue
March 30, 2016
GlucoControl Product Manufacturing Commences
February 25, 2016
Fully Underwritten Rights Issue
February 18, 2016
EVE Investments makes first medical technology investment
February 11, 2016
EVE: Company Update
February 10, 2016
Decks in 2016
- Eve Investments — Merger or Acquisition (February 2016)
Merger or acquisition · 17 slides · Feb 3, 2016